Norditropin and Metformin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Norditropin (somatropin recombinant) and Metformin (metformin hydrochloride). Common drug interactions include diabetes mellitus inadequate control among females and ageusia among males.

The phase IV clinical study analyzes what interactions people have when they take Norditropin and Metformin. It is created by eHealthMe based on reports of 68 people who take the same drugs from the FDA, and is updated regularly.

What is Norditropin?

Norditropin has active ingredients of somatropin recombinant. It is often used in growth hormone deficiency. eHealthMe is studying from 4,920 Norditropin users. Check the latest studies of Norditropin.

What is Metformin?

Metformin has active ingredients of metformin hydrochloride. It is often used in diabetes. eHealthMe is studying from 465,354 Metformin users. Check the latest studies of Metformin.



On Jul, 15, 2026

68 people who take Norditropin and Metformin together, and have interactions are studied.

Norditropin and Metformin drug interactions.

What are the common drug interactions of Norditropin and Metformin, by gender? *:

female:

  1. Diabetes mellitus inadequate control
  2. Drug administration error
  3. Drug ineffective
  4. Fatigue (feeling of tiredness)
  5. Fluid retention (an abnormal accumulation of fluid in the blood)
  6. Groin pain
  7. Heart rate increased
  8. Hyperhidrosis (abnormally increased sweating)
  9. Infusion site reaction
  10. Injection site pain

male:

  1. Ageusia (loss of taste functions of the tongue)
  2. Anaemia (lack of blood)
  3. Skin haemorrhage (bleeding into skin)
  4. Skin lesion
  5. Stomatitis (inflammation of mucous membrane of mouth)
  6. Tongue discolouration (colour change of tongue)
  7. Weight decreased
  8. Tremor (trembling or shaking movements in one or more parts of your body)
  9. Wound complication
  10. Craniopharyngioma (a type of brain tumour derived from pituitary gland embryonic tissue)

What are the common drug interactions of Norditropin and Metformin, by age (0-1 to 60+)? *:

0-1:

  1. Blood insulin increased
  2. Glucose tolerance impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis)
  3. Hyperlipidaemia (presence of excess lipids in the blood)
  4. Insulin resistance
  5. Insulin-like growth factor increased

2-9:

  1. Ear infection
  2. Infusion site pain
  3. Mastoiditis (infection of mastoid bone)
  4. Staphylococcal infection (an infection with staphylococcus bacteria)
  5. Weight fluctuation
  6. Ear discomfort

10-19:

  1. Cardiac arrest
  2. Growth retardation (delayed growth)
  3. Craniopharyngioma (a type of brain tumour derived from pituitary gland embryonic tissue)
  4. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures)
  5. Hyperinsulinaemia (excess levels of insulin circulating in the blood)
  6. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  7. Increased viscosity of bronchial secretion
  8. Secretion discharge
  9. Sputum discoloured
  10. Surgery

20-29:

  1. Urticaria (rash of round, red welts on the skin that itch intensely)
  2. Rash

30-39:

  1. Agitation (state of anxiety or nervous excitement)
  2. Neutrophil count increased (excess than normal number of neutrophil a type of blood cell)
  3. Overdose
  4. Scoliosis (a medical condition in which a person's spine is curved from side to side)
  5. White blood cell count increased
  6. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  7. Hypertension (high blood pressure)

40-49:

  1. Impaired gastric emptying
  2. Neck injury
  3. Seizure (abnormal excessive or synchronous neuronal activity in the brain)

50-59:

  1. Malaise (a feeling of general discomfort or uneasiness)
  2. Diabetes mellitus inadequate control
  3. Diarrhoea
  4. Epididymal enlargement (skin thickening, hydrocele, and hyperaemia)
  5. Faecal incontinence (a lack of control over passing stool)
  6. Injection site pain
  7. Pancreatitis (inflammation of pancreas)
  8. Pulmonary thrombosis (scarring in the lungs)
  9. Skin hypertrophy (skin cells enlarges)
  10. Testicular mass (mass on testes)

60+:

  1. Hyperhidrosis (abnormally increased sweating)
  2. Ageusia (loss of taste functions of the tongue)
  3. Lower limb fracture
  4. Skin haemorrhage (bleeding into skin)
  5. Skin lesion
  6. Stomatitis (inflammation of mucous membrane of mouth)
  7. Tongue discolouration (colour change of tongue)
  8. Weight decreased
  9. Tremor (trembling or shaking movements in one or more parts of your body)
  10. Wound complication

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 6 people, 8.82%
  2. Type 2 Diabetes: 5 people, 7.35%
  3. Hypopituitarism (diminished hormone secretion by the pituitary gland, causing dwarfism in children and premature aging in adults): 5 people, 7.35%
  4. Cystic Fibrosis (disease of the secretary glands): 5 people, 7.35%

* Approximation only. Some reports may have incomplete information.

Do you take Norditropin and Metformin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Norditropin and Metformin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Norditropin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Metformin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Norditropin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Metformin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on somatropin recombinant and metformin hydrochloride (the active ingredients of Norditropin and Metformin, respectively), and Norditropin and Metformin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: